These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 31335164)

  • 1. Kalman Filter-Based Novel Methodology to Assess Insulin Pump Accuracy.
    Girardot S; Mousin F; Vezinet J; Jacquemier P; Hardy S; Riveline JP
    Diabetes Technol Ther; 2019 Oct; 21(10):557-565. PubMed ID: 31335164
    [No Abstract]   [Full Text] [Related]  

  • 2. All Insulin Pumps Are Not Equivalent: A Bench Test Assessment for Several Basal Rates.
    Girardot S; Jacquemier P; Mousin F; Rendekeu C; Hardy S; Riveline JP
    Diabetes Technol Ther; 2020 Jun; 22(6):476-483. PubMed ID: 32069066
    [No Abstract]   [Full Text] [Related]  

  • 3. Accuracy of Bolus and Basal Rate Delivery of Different Insulin Pump Systems.
    Freckmann G; Kamecke U; Waldenmaier D; Haug C; Ziegler R
    Diabetes Technol Ther; 2019 Apr; 21(4):201-208. PubMed ID: 30901232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An online failure detection method of the glucose sensor-insulin pump system: improved overnight safety of type-1 diabetic subjects.
    Facchinetti A; Del Favero S; Sparacino G; Cobelli C
    IEEE Trans Biomed Eng; 2013 Feb; 60(2):406-16. PubMed ID: 23193300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps.
    Potti LG; Haines ST
    J Am Pharm Assoc (2003); 2009; 49(1):e1-13; quiz e14-7. PubMed ID: 19196588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Accuracy of Current Tubeless Pumps for Continuous Subcutaneous Insulin Infusion.
    Ziegler R; Oliver N; Waldenmaier D; Mende J; Haug C; Freckmann G
    Diabetes Technol Ther; 2021 May; 23(5):350-357. PubMed ID: 33210949
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.
    Roze S; Smith-Palmer J; Valentine WJ; Cook M; Jethwa M; de Portu S; Pickup JC
    J Med Econ; 2016; 19(3):236-42. PubMed ID: 26510389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous subcutaneous insulin infusion (CSII) pumps.
    Valla V
    Adv Exp Med Biol; 2012; 771():414-9. PubMed ID: 23393693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin pump therapy in childhood diabetes mellitus: guidelines for use.
    Tamborlane WV; Fredrickson LP; Ahern JH
    Treat Endocrinol; 2003; 2(1):11-21. PubMed ID: 15871551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Description of a Novel Patch Pump for Insulin Delivery and Comparative Accuracy Evaluation.
    Baumstark A; Mende J; Uchiyama J; Haug C; Freckmann G
    J Diabetes Sci Technol; 2022 Jul; 16(4):971-975. PubMed ID: 33736474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experiences of continuous subcutaneous insulin infusion in pregnant women with type 1 diabetes during delivery from four Italian centers: a retrospective observational study.
    Fresa R; Visalli N; Di Blasi V; Cavallaro V; Ansaldi E; Trifoglio O; Abbruzzese S; Bongiovanni M; Agrusta M; Napoli A
    Diabetes Technol Ther; 2013 Apr; 15(4):328-34. PubMed ID: 23537417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Continuous subcutaneous insulin infusion (CSII) in treating young diabetic patients].
    Buczkowska EO; Dworzecki T; Wiedermann G; Malanowicz B; Szot D
    Przegl Lek; 2005; 62(1):49-53. PubMed ID: 16053222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation.
    Cummins E; Royle P; Snaith A; Greene A; Robertson L; McIntyre L; Waugh N
    Health Technol Assess; 2010 Feb; 14(11):iii-iv, xi-xvi, 1-181. PubMed ID: 20223123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification of distinct baseline insulin infusion patterns in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion therapy.
    Holterhus PM; Odendahl R; Oesingmann S; Lepler R; Wagner V; Hiort O; Holl R; ;
    Diabetes Care; 2007 Mar; 30(3):568-73. PubMed ID: 17327322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus].
    Minkina-Pedras M; Jarosz-Chobot P; Małecka-Tendera E; Deja G
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):171-6. PubMed ID: 16232370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous subcutaneous insulin infusion therapy and multiple daily insulin injections in type 1 diabetes mellitus: a comparative overview and future horizons.
    Thabit H; Hovorka R
    Expert Opin Drug Deliv; 2016; 13(3):389-400. PubMed ID: 26618219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
    Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous subcutaneous insulin infusion (CSII) versus multiple daily injections (MDI) of rapid-acting insulin analogues and detemir in type 1 diabetic (T1D) pregnant women.
    Mello G; Biagioni S; Ottanelli S; Nardini C; Tredici Z; Serena C; Marchi L; Mecacci F
    J Matern Fetal Neonatal Med; 2015 Feb; 28(3):276-80. PubMed ID: 24724804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes.
    Colquitt JL; Green C; Sidhu MK; Hartwell D; Waugh N
    Health Technol Assess; 2004 Oct; 8(43):iii, 1-171. PubMed ID: 15488165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.